Novo Nordisk announced the availability of Wegovy® (semaglutide 2.4 mg) (MAL24126014AZ) in Malaysia, an adjunct treatment option for adults living with obesity and overweight who present with at least one weight-related comorbidity.
Health
Jobbie X MAKNA in the ‘Pink Wobbly Breast Odyssey’ Fundraiser
Posted onAbbott Glucerna #StartsWithYou Campaign Empowers Malaysians to Manage Diabetes
Posted onDiabetes is a growing concern worldwide, and in Malaysia, it’s an urgent one. The National Health and Morbidity Survey reports that approximately 3.6 million Malaysians – or 15.6% of the adult population – are living with diabetes, and many more may be undiagnosed. As cases increase, it’s essential to dispel myths, understand the realities of diabetes, and identify effective ways to manage it. To empower Malaysians on this journey, Abbott has launched the Glucerna #StartsWithYou campaign, a movement inspiring positive lifestyle changes and practical diabetes management.
